Page last updated: 2024-11-03

protriptyline and Leishmaniasis, Visceral

protriptyline has been researched along with Leishmaniasis, Visceral in 1 studies

Protriptyline: Tricyclic antidepressant similar in action and side effects to IMIPRAMINE. It may produce excitation.

Leishmaniasis, Visceral: A chronic disease caused by LEISHMANIA DONOVANI and transmitted by the bite of several sandflies of the genera Phlebotomus and Lutzomyia. It is commonly characterized by fever, chills, vomiting, anemia, hepatosplenomegaly, leukopenia, hypergammaglobulinemia, emaciation, and an earth-gray color of the skin. The disease is classified into three main types according to geographic distribution: Indian, Mediterranean (or infantile), and African.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Alcântara, LM1
Ferreira, TCS1
Fontana, V1
Chatelain, E1
Moraes, CB1
Freitas-Junior, LH1

Other Studies

1 other study available for protriptyline and Leishmaniasis, Visceral

ArticleYear
A Multi-Species Phenotypic Screening Assay for Leishmaniasis Drug Discovery Shows That Active Compounds Display a High Degree of Species-Specificity.
    Molecules (Basel, Switzerland), 2020, May-30, Volume: 25, Issue:11

    Topics: Animals; Antiprotozoal Agents; Drug Evaluation, Preclinical; Humans; Leishmania; Leishmaniasis; Leis

2020